Search

Your search keyword '"Tablets analysis"' showing total 124 results

Search Constraints

Start Over You searched for: Descriptor "Tablets analysis" Remove constraint Descriptor: "Tablets analysis" Publisher elsevier science Remove constraint Publisher: elsevier science
124 results on '"Tablets analysis"'

Search Results

1. Development of a new magnetic solid-phase extraction method prior to HPLC determination of naproxen in pharmaceutical products and water samples.

2. Field assessment of active ingredient quantity in pharmaceutical tablets with limited calibration of near infrared spectra: An application to ciprofloxacin tablets.

3. Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry.

4. New HPLC pattern-oriented approach for quality control of enteric coated tablets containing aescin from Aesculus hippocastanum.

5. Detection and structure elucidation of the new degradation impurities in the pharmaceutical formulations of ruxolitinib hydrobromide.

6. Determination of cobalt species in nutritional supplements using ICP-OES after microwave-assisted extraction and solid-phase extraction.

7. A hybrid approach to predict the relationship between tablet tensile strength and compaction pressure using analytical powder compression.

8. Development and validation of an in-line NIR spectroscopic method for continuous blend potency determination in the feed frame of a tablet press.

9. Multivariate calibration of energy-dispersive X-ray diffraction data for predicting the composition of pharmaceutical tablets in packaging.

10. Simultaneous determination of rutin and ascorbic acid in a sequential injection lab-at-valve system.

11. Comparison of the analytical methods (solid state NMR, FT-IR, PXRD) in the analysis of the solid drug forms with low concentration of an active ingredient - 17-β-estradiol case.

12. Development and implementation of a pass/fail field-friendly method for detecting sildenafil in suspect pharmaceutical tablets using a handheld Raman spectrometer and silver colloids.

13. Physicochemical analysis in the evaluation of reconstituted dry emulsion tablets.

14. Fabrication of ciprofloxacin molecular imprinted polymer coating on a stainless steel wire as a selective solid-phase microextraction fiber for sensitive determination of fluoroquinolones in biological fluids and tablet formulation using HPLC-UV detection.

15. Simultaneous determination of domperidone and Itopride in pharmaceuticals and human plasma using RP-HPLC/UV detection: Method development, validation and application of the method in in-vivo evaluation of fast dispersible tablets.

16. Tamper-proof tablets for distinction between counterfeit and originator drugs through PEG coding.

17. Prediction of dissolution profiles by non-destructive near infrared spectroscopy in tablets subjected to different levels of strain.

18. HPTLC and RP-HPLC methods for simultaneous determination of Paracetamol and Pamabrom in presence of their potential impurities.

19. Determination of counterfeit medicines by Raman spectroscopy: Systematic study based on a large set of model tablets.

20. Application of chemometric algorithms to MALDI mass spectrometry imaging of pharmaceutical tablets.

21. Development and validation of LC methods for the separation of misoprostol related substances and diastereoisomers.

22. Stability indicating MEKC method for the determination of gliclazide and its specified impurities.

23. Multivariate figures of merit (FOM) investigation on the effect of instrument parameters on a Fourier transform-near infrared spectroscopy (FT-NIRS) based content uniformity method on core tablets.

24. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies.

25. Risk analysis of analytical validations by probabilistic modification of FMEA.

26. Capillary zone electrophoresis as a potential technique for the simultaneous determination of sulfadoxine and pyrimethamine in tablet formulations.

27. Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations.

28. Development and validation of a liquid chromatographic method for the simultaneous determination of aniracetam and its related substances in the bulk drug and a tablet formulation.

29. Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets.

30. Tablet potency of Tianeptine in coated tablets by near infrared spectroscopy: model optimisation, calibration transfer and confidence intervals.

31. Validation of Raman spectroscopic procedures in agreement with ICH guideline Q2 with considering the transfer to real time monitoring of an active coating process.

32. Counterfeit drugs detection by measurement of tablets and secondary packaging colour.

33. Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy.

34. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study.

35. Quantitative determination of diclofenac sodium in solid dosage forms by FT-Raman spectroscopy.

36. Determination of antibacterial quaternary ammonium compound in lozenges and human serum by resonance light scattering technique.

37. Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection.

38. Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study.

39. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches.

40. The basis function regression in pharmaceutical analysis. Theory and example of application.

41. Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.

42. Generic ciprofloxacin tablets contain the stated amount of drug and different impurity profiles: A 19F, 1H and DOSY NMR analysis.

43. Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode.

44. Improving the detection limits of antispasmodic drugs electrodes by using modified membrane sensors with inner solid contact.

45. Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method.

46. 19F NMR as a powerful technique for the assay of anti-psychotic drug haloperidol in human serum and pharmaceutical formulations.

47. Raman spectroscopy of coated pharmaceutical tablets and physical models for multivariate calibration to tablet coating thickness.

48. Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy.

49. Investigation on the photochemical stability of lercanidipine and its determination in tablets by HPLC-UV and LC-ESI-MS/MS.

50. Rapid separation and determination of resibufogenin and cinobufagin in toad venom and Liushen tablet by beta-cyclodextrin modified micellar electrokinetic chromatography.

Catalog

Books, media, physical & digital resources